Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Grant/Award of 1,322 AVTX shares, $16.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 1,322 | $16.2K |
| Jul 2, 2026 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 1,080 | $16.2K |
| Jun 29, 2026 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 26,000 | n/a |
| Jun 17, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Exercise/Conversion | 7,330 | n/a |
| Jun 4, 2026 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 20,100 | n/a |
| May 14, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 15,000 | n/a |
| Apr 22, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 10,600 | n/a |
| Apr 1, 2026 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 1,339 | $16.2K |
| Jan 8, 2026 | ANAPTYSBIO, INC (ANAB) | Grant/Award | 5,500 | n/a |
| Jan 7, 2026 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 240,000 | n/a |